PJA1 and Alzheimer disease: We further identify spinophilin as a novel PRAJA1 substrate and provide evidence implicating PRAJA1 dysregulation in the synaptic deficits observed in Alzheimer’s disease, highlighting its potential as a therapeutic target for cognitive enhancement.